Regulatory Affairs FAQs
Regulatory Affairs FAQs for Pharma Procurement Teams
Regulatory Affairs FAQs
Regulatory Affairs FAQs for Pharma Procurement Teams
Frequently Asked Questions
How does an FSP model for regulatory affairs differ from traditional staff augmentation?
G&L Scientific’s Functional Service Provider (FSP) model delivers a managed, integrated regulatory team rather than individual contractors.
Unlike traditional staff augmentation, our FSP structure reduces internal management overhead and ensures knowledge continuity throughout the project lifecycle.
This model is designed to support scalable regulatory operations across global markets while maintaining quality oversight and institutional consistency.
How does G&L Scientific mitigate regulatory risk in global submissions?
We apply a “Local Intelligence, Global Strategy” framework, leveraging in-market regulatory expertise across 100+ jurisdictions.
This approach identifies region-specific requirements early in the development process, reducing the risk of Refusal to File or procedural delays. Our structured governance model supports first-cycle approval as a primary objective.
What differentiates G&L Scientific from large full-service CROs?
G&L Scientific provides focused expertise in Regulatory Affairs and Quality without the overhead of a full clinical infrastructure.
This specialization enables competitive cost structures while maintaining senior-level oversight and technical depth.
Clients benefit from global scalability combined with boutique-level strategic attention.
How does G&L support compliance with emerging AI and digital health regulations?
Our consultants monitor evolving regulatory frameworks, including AI governance requirements and machine-learning compliance standards.
We assist clients in validating regulatory information management systems (RIMS) and digital processes to ensure alignment with current FDA and EMA expectations.
Can G&L Scientific rapidly scale regulatory teams for M&A integration?
Yes.
Through our Source platform and global consultant network, we can deploy experienced regulatory professionals across multiple markets within compressed timelines.
This capability supports urgent portfolio transitions, acquisition integrations, and post-merger regulatory continuity.
